Mind the gap in kidney care: translating what we know into what we do

被引:48
作者
Luyckx, Valerie A. [1 ,2 ,3 ]
Tuttle, Katherine R. [4 ,5 ]
Abdellatif, Dina [6 ]
Correa-Rotter, Ricardo [7 ]
Fung, Winston W. S. [8 ]
Haris, Agnes [9 ]
Hsiao, Li-Li [2 ]
Khalife, Makram [10 ]
Kumaraswami, Latha A. [11 ]
Loud, Fiona [10 ]
Raghavan, Vasundhara [10 ]
Roumeliotis, Stefanos [12 ]
Sierra, Marianella [10 ]
Ulasi, Ifeoma [13 ]
Wang, Bill [10 ]
Lui, Siu-Fai [14 ]
Liakopoulos, Vassilios [12 ,15 ]
Balducci, Alessandro [16 ]
机构
[1] Univ Zurich, Epidemiol Biostat & Prevent Inst, Dept Publ & Global Hlth, Zurich, Switzerland
[2] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Renal Div, Boston, MA USA
[3] Univ Cape Town, Dept Paediat & Child Hlth, Cape Town, South Africa
[4] Providence Inland Northwest Hlth, Providence Med Res Ctr, Spokane, WA USA
[5] Univ Washington, Dept Med, Nephrol Div, Seattle, WA USA
[6] Cairo Univ Hosp, Dept Nephrol, Cairo, Egypt
[7] Natl Med Sci & Nutr Inst Salvador Zubiran, Dept Nephrol & Mineral Metab, Mexico City, Mexico
[8] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China
[9] Peterfy Hosp, Nephrol Dept, Budapest, Hungary
[10] ISN Patient Liaison Advisory Grp, Dublin, Ireland
[11] Tamilnad Kidney Res TANKER Fdn, Chennai, India
[12] Aristotle Univ Thessaloniki, AHEPA Univ Hosp, Dept Nephrol 2, Med Sch, Thessaloniki, Greece
[13] Univ Nigeria, Coll Med, Dept Med, Ituku Ozalla, Enugu, Nigeria
[14] Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Div Hlth Syst Policy & Management, Hong Kong, Peoples R China
[15] Aristotle Univ Thessaloniki, Dept Nephrol 2, Sch Med, Ahepa Univ Hosp, Thessaloniki, Italy
[16] Italian Kidney Fdn, Rome, Italy
关键词
chronic kidney disease; equity; kidney care; public health; World Kidney Day; MIDDLE-INCOME; DISEASE; CKD; MANAGEMENT; MEDICINES; BARRIERS; OUTCOMES; BURDEN; RISK;
D O I
10.1016/j.kint.2023.12.003
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Historically, it takes an average of 17 years to move new treatments from clinical evidence to daily practice. Given the highly effective treatments now available to prevent or delay kidney disease onset and progression, this is far too long. The time is now to narrow the gap between what we know and what we do. Clear guidelines exist for the prevention and management of common risk factors for kidney disease, such as hypertension and diabetes, but only a fraction of people with these conditions worldwide are diagnosed, and even fewer are treated to target. Similarly, the vast majority of people living with kidney disease are unaware of their condition, because in the early stages it is often silent. Even among patients who have been diagnosed, many do not receive appropriate treatment for kidney disease. Considering the serious consequences of kidney disease progression, kidney failure, or death, it is imperative that treatments are initiated early and appropriately. Opportunities to diagnose and treat kidney disease early must be maximized beginning at the primary care level. Many systematic barriers exist, ranging from patient to clinician to health systems to societal factors. To preserve and improve kidney health for everyone everywhere, each of these barriers must be acknowledged so that sustainable solutions are developed and implemented without further delay.
引用
收藏
页码:406 / 417
页数:12
相关论文
共 67 条
[11]   Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study [J].
Ene-Iordache, Bogdan ;
Perico, Norberto ;
Bikbov, Boris ;
Carminati, Sergio ;
Remuzzi, Andrea ;
Perna, Annalisa ;
Islam, Nazmul ;
Bravo, Rodolfo Flores ;
Aleckovic-Halilovic, Mirna ;
Zou, Hequn ;
Zhang, Luxia ;
Gouda, Zaghloul ;
Tchokhonelidze, Irma ;
Abraham, Georgi ;
Mahdavi-Mazdeh, Mitra ;
Gallieni, Maurizio ;
Codreanu, Igor ;
Togtokh, Ariunaa ;
Sharma, Sanjib Kumar ;
Koirala, Puru ;
Uprety, Samyog ;
Ulasi, Ifeoma ;
Remuzzi, Giuseppe .
LANCET GLOBAL HEALTH, 2016, 4 (05) :E307-E319
[12]   EMPA-KIDNEY: expanding the range of kidney protection by SGLT2 inhibitors [J].
Fernandez-Fernandez, Beatriz ;
Sarafidis, Pantelis ;
Soler, Maria Jose ;
Ortiz, Alberto .
CLINICAL KIDNEY JOURNAL, 2023, 16 (08) :1187-1198
[13]   Barriers to accessing essential medicines for kidney disease in low- and lower middle-income countries [J].
Francis, Anna ;
Hafidz, Muhammad Iqbal Abdul ;
Ekrikpo, Udeme E. ;
Chen, Titi ;
Wijewickrama, Eranga ;
Tannor, Elliot K. ;
Nakhoul, Georges ;
Wong, Michelle M. Y. ;
Pereira-Kamath, Nikhil ;
Chanchlani, Rahul ;
Kalyesubula, Robert ;
Karam, Sabine ;
Kumar, Vivek ;
Calice-Silva, Viviane ;
Jha, Vivekanand .
KIDNEY INTERNATIONAL, 2022, 102 (05) :969-973
[14]   The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1.1 million adults [J].
Geldsetzer, Pascal ;
Manne-Goehler, Jennifer ;
Marcus, Maja-Emilia ;
Ebert, Cara ;
Zhumadilov, Zhaxybay ;
Wesseh, Chea S. ;
Tsabedze, Lindiwe ;
Supiyev, Adil ;
Sturua, Lela ;
Bahendeka, Silver K. ;
Sibai, Abla M. ;
Quesnel-Crooks, Sarah ;
Norov, Bolormaa ;
Mwangi, Kibachio J. ;
Mwalim, Omar ;
Wong-McClure, Roy ;
Mayige, Mary T. ;
Martins, Joao S. ;
Lunet, Nuno ;
Labadarios, Demetre ;
Karki, Khem B. ;
Kagaruki, Gibson B. ;
Jorgensen, Jutta M. A. ;
Hwalla, Nahla C. ;
Houinato, Dismand ;
Houehanou, Corine ;
Msaidie, Mohamed ;
Guwatudde, David ;
Gurung, Mongal S. ;
Gathecha, Gladwell ;
Dorobantu, Maria ;
Damasceno, Albertino ;
Bovet, Pascal ;
Bicaba, Brice W. ;
Aryal, Krishna K. ;
Andall-Brereton, Glennis ;
Agoudavi, Kokou ;
Stokes, Andrew ;
Davies, Justine I. ;
Baernighausen, Till ;
Atun, Rifat ;
Vollmer, Sebastian ;
Jaacks, Lindsay M. .
LANCET, 2019, 394 (10199) :652-662
[15]   Risks of Adverse Events in Advanced CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study [J].
Grams, Morgan E. ;
Yang, Wei ;
Rebholz, Casey M. ;
Wang, Xue ;
Porter, Anna C. ;
Inker, Lesley A. ;
Horwitz, Edward ;
Sondheimer, James H. ;
Hamm, L. Lee ;
He, Jiang ;
Weir, Matthew R. ;
Jaar, Bernard G. ;
Shafi, Tariq ;
Appel, Lawrence J. ;
Hsu, Chi-yuan .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2017, 70 (03) :337-346
[16]   Improving health outcomes of people with diabetes: target setting for the WHO Global Diabetes Compact [J].
Gregg, Edward W. ;
Buckley, James ;
Ali, Mohammed K. ;
Davies, Justine ;
Flood, David ;
Mehta, Roopa ;
Griffiths, Ben ;
Lim, Lee-Ling ;
Manne-Goehler, Jennifer ;
Pearson-Stuttard, Jonathan ;
Tandon, Nikhil ;
Roglic, Gojka ;
Slama, Slim ;
Shaw, Jonathan E. .
LANCET, 2023, 401 (10384) :1302-1312
[17]   A Systematic Study of the Prevalence and Risk Factors of CKD in Uddanam, India [J].
Gummidi, Balaji ;
John, Oommen ;
Ghosh, Arpita ;
Modi, Gopesh K. ;
Sehgal, Meena ;
Kalra, Om P. ;
Kher, Vijay ;
Muliyil, Jayaprakash ;
Thakur, Jarnail S. ;
Ramakrishnan, Lakshmy ;
Pandey, Chandra M. ;
Sivakumar, Vishnubhotla ;
Dhaliwal, Rupinder S. ;
Khanna, Tripti ;
Kumari, Aruna ;
Prasadini, Geetha ;
Reddy, Janardhan C. ;
Reddy, Jawahar ;
Jha, Vivekanand .
KIDNEY INTERNATIONAL REPORTS, 2020, 5 (12) :2246-2255
[18]   Estimated lifetime benefit of novel pharmacological therapies in patients with type 2 diabetes and chronic kidney disease: A joint analysis of randomized controlled clinical trials [J].
Heerspink, Hiddo J. L. ;
Vart, Priya ;
Jongs, Niels ;
Neuen, Brendon L. ;
Bakris, George ;
Claggett, Brian ;
Vaduganathan, Muthiah ;
McCausland, Finnian ;
Docherty, Kieran F. ;
Jhund, Pardeep S. ;
Solomon, Scott D. ;
Perkovic, Vlado ;
McMurray, John J. V. .
DIABETES OBESITY & METABOLISM, 2023, 25 (11) :3327-3336
[19]   Shared decision making: a personal view from two kidney doctors and a patient [J].
Hole, Barnaby ;
Scanlon, Miranda ;
Tomson, Charlie .
CLINICAL KIDNEY JOURNAL, 2023, 16 :i12-i19
[20]  
Institute for Health Metrics and Evaluation (IHME), GBD compare data visualization 2017